Skip to Main Content

Author Details

Carolina Lucas
Yale School of Medicine
2014
32
15
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36596303PD-1<sup>high</sup>CXCR5<sup>-</sup>CD4<sup>+</sup> peripheral helper T cells promote CXCR3<sup>+</sup> plasmablasts in human acute viral infection.Cell Rep2023
37748514Distinguishing features of long COVID identified through immune profiling.Nature2023
37146127Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis.Sci Immunol2023
36974986Nonsystematic Reporting Biases of the SARS-CoV-2 Variant Mu Could Impact Our Understanding of the Epidemiological Dynamics of Emerging Variants.Genome Biol Evol2023
37036977Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants.Proc Natl Acad Sci U S A2023
36879038Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens.Cell Res2023
36894554SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity.Nat Commun2023
34718647Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient.J Infect Dis2022
35547852SARS-CoV-2 Omicron subvariants evolved to promote further escape from MHC-I recognition.bioRxiv2022
35378749Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu.medRxiv2022
35609110No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.PLoS Biol2022
35853867Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2.Cell Discov2022
36220819Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5.Cell Discov2022
35051990Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination.Nat Med2022
35228707Multiscale PHATE identifies multimodal signatures of COVID-19.Nat Biotechnol2022
34757384A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice.J Exp Med2022
34230210Kynurenic acid may underlie sex-specific immune responses to COVID-19.Sci Signal2021
34460832Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel.PLoS One2021
33969321Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms.Cell Rep Med2021
34159330A stem-loop RNA RIG-I agonist confers prophylactic and therapeutic protection against acute and chronic SARS-CoV-2 infection in mice.bioRxiv2021
34145437Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19.Nat Med2021
32381717Contributions of maternal and fetal antiviral immunity in congenital disease.Science2020
33398304Kinetics of antibody responses dictate COVID-19 outcome.medRxiv2020
32577695Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes.medRxiv2020
32935102Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement.bioRxiv2020
32846427Sex differences in immune responses that underlie COVID-19 disease outcomes.Nature2020
30087337Critical role of CD4<sup>+</sup> T cells and IFNγ signaling in antibody-mediated resistance to Zika virus infection.Nat Commun2018
29813061Viral immunogenicity determines epidemiological fitness in a cohort of DENV-1 infection in Brazil.PLoS Negl Trop Dis2018
29312238Zika Virus Infects, Activates, and Crosses Brain Microvascular Endothelial Cells, without Barrier Disruption.Front Microbiol2017
27199296Dendritic cells primed with a chimeric plasmid containing HIV-1-gag associated with lysosomal-associated protein-1 (LAMP/gag) is a potential therapeutic vaccine against HIV.FASEB J2016
26378174Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.J Virol2015
24932692Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response.PLoS One2014
  • 1 - 32 of 32

Recommended Authors

Sebastian Weigang
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year 2018
Number of shared co-authors 0
Rishi R Goel
Institute for Immunology, University of Pennsylvania Perelman School of Medicine
Career Start Year 2018
Number of shared co-authors 1
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 0
Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 0
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 0
Wilfredo F Garcia-Beltran
Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 1
Diego S Ojeda
Fundacion Instituto Leloir-CONICET
Career Start Year 2012
Number of shared co-authors 0
Yiska Weisblum
Rockefeller University
Career Start Year 2011
Number of shared co-authors 0
Meagan E Deming
University of Maryland School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Vineet D Menachery
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 2
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 0
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 0
Melissa M Coughlin
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 0
Pavlo Gilchuk
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 0
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 1
Lingshu Wang
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 0
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year 2003
Number of shared co-authors 0
Fabian Schmidt
The Rockefeller University
Career Start Year 2002
Number of shared co-authors 0
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 0
Paul G Thomas
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 0
Timothy H Burgess
Infectious Disease Clinical Research Program, Uniformed Services University
Career Start Year 2000
Number of shared co-authors 0
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 0
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 1
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 1
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 3
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 1
Gregory A Poland
Mayo Clinic Vaccine Research Group
Career Start Year 1985
Number of shared co-authors 1
Michael S Diamond
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 3
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 2
James E Crowe
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 0

Collaborators

Akiko Iwasaki
Yale University
Co-authored papers 21
Nathan D Grubaugh
Yale School of Public Health
Co-authored papers 14
Albert I Ko
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers 13
Tianyang Mao
Yale University School of Medicine
Co-authored papers 12
Chantal B F Vogels
Yale School of Public Health
Co-authored papers 12
Saad B Omer
Yale School of Public Health
Co-authored papers 11
Aaron M Ring
Yale University School of Medicine
Co-authored papers 10
Shelli F Farhadian
Yale School of Medicine
Co-authored papers 9
Benjamin Israelow
Yale University School of Medicine
Co-authored papers 9
Arnau Casanovas-Massana
School of Public Health, Yale University
Co-authored papers 9
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Co-authored papers 9
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers 8
Patrick Wong
Yale School of Medicine
Co-authored papers 8
Inci Yildirim
Emory University School of Medicine
Co-authored papers 8
Peiwen Lu
Yale University School of Medicine
Co-authored papers 6
Craig B Wilen
Yale School of Medicine
Co-authored papers 5
M Catherine Muenker
Yale School of Public Health
Co-authored papers 5
Maria Tokuyama
Yale University School of Medicine
Co-authored papers 5
Anne L Wyllie
Yale School of Public Health
Co-authored papers 5
Adam J Moore
Yale School of Public Health
Co-authored papers 5
Arvind Venkataraman
Christian Medical College
Co-authored papers 4
Albert C Shaw
Yale School of Medicine, Yale University
Co-authored papers 4
Subhasis Mohanty
Yale School of Medicine, Yale University
Co-authored papers 4
Eric Song
Yale University
Co-authored papers 3
Mary E Petrone
Sydney Institute for Infectious Diseases, The University of Sydney
Co-authored papers 3
John B Fournier
Yale University School of Medicine
Co-authored papers 3
Adam V Wisnewski
Yale University School of Medicine
Co-authored papers 3
Wade Schulz (CM4AI)
Yale University
Co-authored papers 3
Joseph R Fauver
University of Nebraska Medical Center
Co-authored papers 3
Isabel M Ott
Yale School of Public Health
Co-authored papers 3
Release 1.2